US Health Department Collaborating With Biotech Company to Create Coronavirus Treatment

US Health Department Collaborating With Biotech Company to Create Coronavirus Treatment
A transmission electron microscopy image of the first isolated case of the coronavirus, on Jan. 27, 2020. Handout via Reuters
|Updated:
The Department of Health and Human Services (HHS) will collaborate with Regeneron Pharmaceuticals to develop new treatments to combat the Novel Coronavirus, 2019-nCoV, it announced on Feb. 4.
The New York-based biotechnology company Regeneron Pharmaceuticals will work in partnership with the department to develop “multiple monoclonal antibodies” that could be used individually or in combination to treat the virus, according to a press statement.
Katabella Roberts
Katabella Roberts
Author
Katabella Roberts is a news writer for The Epoch Times, focusing primarily on the United States, world, and business news.
Related Topics